HN2000000242A - Derivados de higromicina - Google Patents

Derivados de higromicina

Info

Publication number
HN2000000242A
HN2000000242A HN2000000242A HN2000000242A HN2000000242A HN 2000000242 A HN2000000242 A HN 2000000242A HN 2000000242 A HN2000000242 A HN 2000000242A HN 2000000242 A HN2000000242 A HN 2000000242A HN 2000000242 A HN2000000242 A HN 2000000242A
Authority
HN
Honduras
Prior art keywords
hygromycin
derivatives
hygromycin derivatives
present
invention refers
Prior art date
Application number
HN2000000242A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to HN2000000242A priority Critical patent/HN2000000242A/es
Publication of HN2000000242A publication Critical patent/HN2000000242A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A DERIVADOS DE HIGROMICINA
HN2000000242A 2000-10-26 2000-10-26 Derivados de higromicina HN2000000242A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HN2000000242A HN2000000242A (es) 2000-10-26 2000-10-26 Derivados de higromicina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HN2000000242A HN2000000242A (es) 2000-10-26 2000-10-26 Derivados de higromicina

Publications (1)

Publication Number Publication Date
HN2000000242A true HN2000000242A (es) 2001-04-11

Family

ID=53190389

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2000000242A HN2000000242A (es) 2000-10-26 2000-10-26 Derivados de higromicina

Country Status (1)

Country Link
HN (1) HN2000000242A (es)

Similar Documents

Publication Publication Date Title
HN2001000139A (es) Interleuquina 2 estabilizada
HN1999000089A (es) Formulaciones de ziprasidona
HN1999000125A (es) Nuevos derivados sustituidos del pirazol
HN1999000155A (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
HN1998000057A (es) Derivados de nicotinamida
HN1999000066A (es) Formulaciones farmaceuticas
HN1998000030A (es) 2-amino-6-(4fenoxi-2-sustituido)-piridinas sustituidas
HN1998003689A (es) Azetidinas
HN1998000158A (es) Isoquinolinas
HN1998000106A (es) Composiciones parenterales de alatroflaxacino
HN1998000199A (es) Agentes terapeuticos
PA8543701A1 (es) Fenil-heterociclil-eteres
HN1998000102A (es) Composiciones solubilizadas de sertralina
HN1999000202A (es) Derivados de higromicina
HN2000000242A (es) Derivados de higromicina
HN2000000276A (es) Derivados de tiazolilamida
HN2001000135A (es) Derivados de purina
HN2000000188U (es) Arado combinado
HN2000000205A (es) Derivados de purina
HN1998000072A (es) Tetrazoles
HN2000000062A (es) Compuestos de benzolactama sustituidos
HN2000000247A (es) Quimioterapia de combinacion
HN2000000015A (es) Sistema electronico dannilma
HN1999000171A (es) Concentrado oral de sertralina.
HN2000000064A (es) Compuestos quimicos